Results 81 to 90 of about 21,448 (153)

Severe Lithium Toxicity due to the Use of Unauthorized Weight Loss Medication

Bipolar Disorders, Volume 28, Issue 2, March 2026.
Georgios Ydraios, Rayan Nasserdine, Emilie Duret, Stergios Tsartsalis, Hélène Richard‐Lepouriel   +4 more
wiley   +1 more source

Assessing effectiveness of aripiprazole lauroxil vs placebo for the treatment of schizophrenia using number needed to treat and number needed to harm

Neuropsychiatric Disease and Treatment, 2019
Leslie Citrome,1 Yangchun Du,2 Peter J Weiden3 1Psychiatry and Behavioral Sciences, New York Medical College, Valhalla, NY, USA; 2Biostatistics, Alkermes, Inc., Waltham, MA, USA; 3Medical Affairs, Alkermes, Inc., Waltham, MA, USACorrespondence: Leslie ...
Citrome L, Du Y, Weiden PJ
doaj  

Solubility Behaviour of Aripiprazole in Different Solvent Systems

RGUHS Journal of Pharmaceutical Sciences
Background This current research work discusses the Aripiprazolersquos solubility behaviour in individual solvents and solvent blends to offer some theoretical foundation for the formulation scientists regarding solute solvent ...
Sharda Sambhakar, Shwetha S Kamath K, Thimmasetty J, Shashank Nayak N, Bishambar Singh, Paramita Das   +5 more
doaj   +1 more source

Useful considerations for treating migraine in patients with autism

Headache: The Journal of Head and Face Pain, Volume 66, Issue 3, Page 768-770, March 2026.
Sinifunanya E. Nwaobi
wiley   +1 more source

Randomized, double-blind, placebo-controlled trial of aripiprazole oral solution in children and adolescents with Tourette’s disorder

Child and Adolescent Psychiatry and Mental Health
Background Aripiprazole is the most frequently recommended antipsychotic for the treatment of tics in children and adolescents with Tourette’s disorder (TD).
Fan He, Jie Luo, Yi Huang, Yunpeng Hao, Ling Sun, Xiaoyan Ke, Bin Wu, Yucai Chen, Ying Han, Yuebing Zhang, Jing Liu, Hong Han, Mingji Xian, Motomichi Uki, Yi Zheng   +14 more
doaj   +1 more source

Review of depot aripiprazole for schizophrenia

Patient Preference and Adherence, 2013
Farha Bilal Motiwala, Kim Stasia Siscoe, Rif S El-Mallakh Mood Disorders Research Program, Department of Psychiatry and Behavioral Sciences, University of Louisville School of Medicine, Louisville, KY, USA Abstract: Improving outcomes in schizophrenia ...
Motiwala FB, Siscoe KS, El-Mallakh RS
doaj  

Low-dose aripiprazole for refractory burning mouth syndrome

Neuropsychiatric Disease and Treatment, 2016
Yojiro Umezaki,1 Miho Takenoshita,2 Akira Toyofuku2 1Psychosomatic Dentistry Clinic, Dental Hospital, 2Psychosomatic Dentistry, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan Abstract: We report a case
Umezaki Y, Takenoshita M, Toyofuku A
doaj  

Influence of CYP2D6 Genotypes and Phenotypes on the Plasma Levels and Clinical Response to Aripiprazole. [PDF]

Schizophr Bull
Gras C, Piras M, Ranjbar S, Grosu C, Girardin FR, Vandenberghe F, Ansermot N, Grandjean C, Kaiser S, Gamma F, Plessen KJ, von Gunten A, Conus P, Crettol S, Eap CB.   +14 more
europepmc   +1 more source

Levels of aripiprazole in the blood with an injection of aripiprazole administered once every two months: a plain language summary of publication. [PDF]

Ther Adv Psychopharmacol
Wang Y, Harlin M, Larsen F, Wang X, Park W, Rich B, Gobburu JV, Raoufinia A.   +7 more
europepmc   +1 more source

Oculogyric Crisis During Chronic Aripiprazole Therapy: A Diagnostic Challenge in the Emergency Department. [PDF]

Clin Case Rep
Tokioka K, Nojima T, Matsuo I, Tsukahara K, Nakao A.   +4 more
europepmc   +1 more source